abagovomab 27
abciximab 24
abituzumab 23
abrilumab 21
actoxumab 13
adalimumab 17
aducanumab 11
afasevikumab 17
alacizumab_pegol 11
alemtuzumab 26
alirocumab 22
amatuximab 38
andecaliximab 23
anifrolumab 18
anrukinzumab 17
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 18
ascrinvacumab 7
atezolizumab 16
atinumab 16
avelumab 12
basiliximab 28
bavituximab 35
begelomab 22
benralizumab 28
bevacizumab_beta 20
bezlotoxumab 13
bimagrumab 17
bleselumab 14
blinatumomab 26
blosozumab 29
bococizumab 18
brazikumab 18
brentuximab_vedotin 33
briakinumab 19
brodalumab 7
brolucizumab 27
brontictuzumab 29
burosumab 19
cabiralizumab 28
camrelizumab 14
canakinumab 23
cantuzumab_ravtansin 38
carlumab 15
carotuximab 24
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 26
cetiximab 39
citatuzumab_bogatox 27
cixutumumab 26
clivatuzumab_tetraxetan 16
codrituzumab 30
conatumumab 11
concizumab 28
crenezumab 22
crizanlizumab 27
crotedumab 21
dacetuzumab 23
daclizumab 16
dalotuzumab 30
dapirolizumab_pegol 26
daratumumab 13
dectrekumab 10
demcizumab 21
denosumab 8
depatuxizumab 22
depatuxizumab_mafodotin 22
dezamizumab 23
dinutuximab 30
diridavumab 21
domagrozumab 17
drozitumab 15
duligotuzumab 20
durvalumab 8
dusigitumab 20
efalizumab 34
efungumab 28
eldelumab 17
elezanumab 21
elgemtumab 13
elotuzumab 16
emactuzumab 20
emapalumab 26
emibetuzumab 19
enavatuzumab 24
enfortumab_vedotin 15
enoblituzumab 17
enokizumab 25
enoticumab 19
ensituximab 29
eptinezumab 16
erenumab 21
etaracizumab 15
etrolizumab 22
evinacumab 22
evolocumab 17
farletuzumab 3
fasinumab 23
fezakinumab 22
fibatuzumab 13
ficlatuzumab 24
firivumab 31
flanvotumab 17
fletikumab 23
foralumab 13
foravirumab 15
fremanezumab 29
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 20
ganitumab 20
gantenerumab 14
gemetuzumab 28
gemtuzumab2 27
gemtuzumab 25
gevokizumab 21
girentuximab 29
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 20
ibalizumab 28
ibritumomab 28
icrucumab 11
idarucizumab 29
ifabotuzumab 13
imalumab 18
imgatuzumab 22
inclacumab 21
indatuximab_ravtansin 27
indusatumab 16
inebilizumab 25
intetumumab 12
iodine_girentuximab 29
ipilimumab 7
iratumumab 11
isatuximab 32
itolizumab 22
ixekizumab 31
labetuzumab_govitecan 21
lambrolizumab 27
lampalizumab 26
lanadelumab 19
landogrozumab 19
laprituximab 28
lebrikizumab 37
lendalizumab 26
lenzilumab 17
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 37
lirilumab 25
lodelcizumab 19
lokivetmab 25
lorvotuzumab_mertansin 22
lucatumumab 30
lumretuzumab 19
lupartumab 17
lutikizumab 19
margetuximab 30
milatuzumab 37
mirvetuximab 30
mirvetuximab_soravtansin 30
modotuximab 37
mogamulizumab 28
monalizumab 22
motavizumab 33
moxetumomab_pasudotox 23
namilumab 23
naratuximab 27
naratuximab_emtansin 27
narnatumab 16
navicixizumab2 26
navicixizumab 23
navivumab 34
necitumumab 10
nemolizumab 25
nesvacumab 17
nivolumab 12
obiltoxaximab 20
obinutuzumab 31
ocaratuzumab 23
ofatumumab 19
olaratumab 18
olokizumab 24
omalizumab 19
onartuzumab 22
ontuxizumab 26
opicinumab 13
orticumab 13
otelixizumab 36
oxelumab 13
ozanezumab 32
pamrevlumab 13
panobacumab 24
parsatuzumab 29
pasotuxizumab 22
pateclizumab 17
patritumab 17
pembrolizumab 27
perakizumab 24
pidilizumab 15
pinatuzumab_vedotin 19
plozalizumab 26
pogalizumab 25
polatuzumab_vedotin 22
ponezumab 33
prezalumab 15
pritoxaximab 35
quilizumab 21
racotumomab 28
radretumab 14
ralpancizumab 23
ramucirumab 13
ranevetmab 29
ranibizumab 21
refanezumab 22
remtolumab 20
rilotumumab 15
rinucumab 16
risankizumab 30
rituximab 21
rivabazumab 23
robatumumab 20
roledumab 32
romosozumab 21
rontalizumab 23
rosmantuzumab 23
rozanolixizumab 22
sacituzumab 27
sacituzumab_govitecan 27
samalizumab 28
sapelizumab 24
sarilumab 17
secukinumab 15
seribantumab 16
setoxaximab 39
sifalimumab 12
siltuximab 17
simtuzumab 27
sirukumab 12
solanezumab 27
solitomab 26
stamulumab 18
suptavumab 22
suvizumab 20
tabalumab 12
tadocizumab 16
tamtuvetmab 31
tanezumab 23
tarextumab 11
tavolixizumab 13
telisotuzumab 29
teplizumab 22
tesidolumab 22
tezepelumab 25
tigatuzumab 16
tildrakizumab 23
timolumab 14
tisotumab 11
tosatoxumab 32
tositumomab 25
tralokinumab 24
trastuzumab 24
tregalizumab 22
trevogrumab 12
ublituximab 26
urelumab 17
ustekinumab 27
utomilumab 26
vadastuximab 24
vadastuximab_talirin 24
vandortuzumab_vedotin 19
vantictumab 19
vanucizumab2 20
vanucizumab 30
varlilumab 16
vatelizumab 18
vedolizumab 26
veltuzumab 16
vesencumab 10
vorsetuzumab 20
vorsetuzumab_mafodotin 20
vunakizumab 30
xentuzumab 17
zatuximab 37
